CAS: 956707-04-3

8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide (compound 3), a sesquiterpene, exhibits anti-LIMK1 activity and inhibits cell motility [1].

8Beta,9Alpha-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide is a sesquiterpene lactone, which is a secondary metabolite predominantly isolated from plants, often in the Asteraceae family. These bioactive compounds are known for their diverse therapeutic potential, particularly in anticancer and anti-inflammatory applications. The mode of action typically involves the modulation of signaling pathways and the inhibition of transcription factors such as NF-kB, which plays a crucial role in inflammatory responses and cell survival. This product is being investigated for its potential uses in medical research due to its bioactivity. Its ability to selectively target specific pathways makes it a subject of interest in the development of new pharmacological interventions. Specifically, its potential to induce apoptosis in cancer cells and modulate immune responses highlights its importance in therapeutic research, aiming to address complex conditions such as cancer and chronic inflammatory diseases. Further investigations in its pharmacokinetics and toxicological profile are essential to fully harness its therapeutic potential.